These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15100323)

  • 1. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin.
    Yang CD; Hwang KK; Yan W; Gallagher K; FitzGerald J; Grossman JM; Hahn BH; Chen PP
    J Immunol; 2004 May; 172(9):5765-73. PubMed ID: 15100323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.
    Yang YH; Hwang KK; FitzGerald J; Grossman JM; Taylor M; Hahn BH; Chen PP
    J Immunol; 2006 Dec; 177(11):8219-25. PubMed ID: 17114499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice.
    Chen XX; Gu YY; Li SJ; Qian J; Hwang KK; Chen PP; Chen SL; Yang CD
    J Immunol; 2007 Apr; 178(8):5351-6. PubMed ID: 17404320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin.
    Kolev K; Gombás J; Váradi B; Skopál J; Mede K; Pitlik E; Nagy Z; Machovich R
    Thromb Haemost; 2002 Mar; 87(3):502-8. PubMed ID: 11916083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin.
    Yang YH; Chien D; Wu M; FitzGerald J; Grossman JM; Hahn BH; Hwang KK; Chen PP
    J Immunol; 2009 Feb; 182(3):1674-80. PubMed ID: 19155517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin.
    Hwang KK; Grossman JM; Visvanathan S; Chukwuocha RU; Woods VL; Le DT; Hahn BH; Chen PP
    J Immunol; 2001 Dec; 167(12):7192-8. PubMed ID: 11739542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of antiphospholipid antibodies on the formation and lysis of fibrin network in patients with recurrent miscarriage].
    Marchi R; Maya I; Garmendia J
    Invest Clin; 2011 Mar; 52(1):35-47. PubMed ID: 21614812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
    Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
    Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins.
    Gombás J; Tanka-Salamon A; Skopál J; Nagy Z; Machovich R; Kolev K
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):82-8. PubMed ID: 18180621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation.
    Chuang YC; Lei HY; Lin YS; Liu HS; Wu HL; Yeh TM
    J Immunol; 2011 Dec; 187(12):6483-90. PubMed ID: 22079981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis.
    Lambrianides A; Turner-Stokes T; Pericleous C; Ehsanullah J; Papadimitraki E; Poulton K; Ioannou Y; Lawrie A; Mackie I; Chen P; Latchman D; Isenberg D; Rahman A; Giles I
    Arthritis Rheum; 2011 Nov; 63(11):3512-21. PubMed ID: 21739425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation.
    Bu C; Gao L; Xie W; Zhang J; He Y; Cai G; McCrae KR
    Arthritis Rheum; 2009 Feb; 60(2):559-68. PubMed ID: 19180513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the fibrinolytic process in a patient with antiphospholipid syndrome.
    Marchi R; Garmendia J; Kanzler D; Fuenmayor J
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):239-45. PubMed ID: 24418942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Koike T
    Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmin immunization preferentially induces potentially prothrombotic IgG anticardiolipin antibodies in MRL/MpJ mice.
    Ede K; Hwang KK; Wu CC; Wu M; Yang YH; Lin WS; Chien D; Chen PC; Tsao BP; McCurdy DK; Chen PP
    Arthritis Rheum; 2009 Oct; 60(10):3108-17. PubMed ID: 19790056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A2 autoantibodies in thrombosis and autoimmune diseases.
    Cañas F; Simonin L; Couturaud F; Renaudineau Y
    Thromb Res; 2015 Feb; 135(2):226-30. PubMed ID: 25533130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
    Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
    Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
    Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
    Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.
    Vikerfors A; Svenungsson E; Ågren A; Mobarrez F; Bremme K; Holmström M; Eelde A; Bruzelius M; Elgue G; Wallén H; Antovic A
    Thromb Res; 2014 May; 133(5):936-44. PubMed ID: 24630645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.